Could a widely available drug reduce COVID-19 mortality?
CHÉOS Statistician Dr. Terry Lee joined researchers investigating whether angiotensin receptor blockers and ACE inhibitors could be viable treatment options for COVID-19
Read MoreCHÉOS Statistician Dr. Terry Lee joined researchers investigating whether angiotensin receptor blockers and ACE inhibitors could be viable treatment options for COVID-19
Read MoreA clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read MoreCHÉOS Project Manager Judy Needham recently accepted an award on behalf of the CRPBC. We spoke with Judy to learn more about the CRPBC and the award
Read MoreAs scientists around the world, including a team at St. Paul's Hospital, are racing to find an effective treatment for COVID-19, CHÉOS project managers are proud to be a small part of this global effort.
Read MoreNew research led by CHÉOS Trainee Rebecca Metcalfe shows that women have diverse needs for shared decision making in pregnancy
Read MoreCHÉOS researcher Dr. Joel Singer is part of an international team that recently received federal funding to help combat the COVID-19 pandemic
Read More